2,3,6-Trimethylquinoxaline

Catalog No.: 
ACBCUV045
CAS No.: 
17635-21-1
Molecular Formula: 
C11H12N2
Molecular Weight: 
172.23
2,3,6-Trimethylquinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$53.00In stockIn stock
100g95%$207.00In stockIn stock
500g95%$811.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3,6-Trimethylquinoxaline
IUPAC Name2,3,6-trimethylquinoxaline
MDL No.MFCD00047593
Molecular FormulaC11H12N2
Molecular Weight172.23
SMILESCC1=CC=C2N=C(C)C(C)=NC2=C1
InChI KeyGQRWKGBOBWHKHP-UHFFFAOYSA-N
Synonym2,3,6-TRIMETHYLQUINOXALINE;2,3,7-TRIMETHYLQUINOXALINE;2,3,6-trimethyl-quinoxalin;EINECS 241-618-2;6-Methyl-2,3-dimethylquinoxaline;Quinoxaline, 2,3,6-trimethyl-
CAS No.17635-21-1
PubChem CID87204

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335-H412
Precautionary Statement(s)
P261-P273-P305+P351+P338

Synthetic Route by SureRoute

1. ACBCUV045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXUM985 route compound structure diagram
    ACJXUM985496-72-0In Stock
  4. Then
  5. ACBCUV045 route product structure diagram
    ACBCUV04517635-21-1In Stock
Inquiry

2. ACBCUV045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCUV045 route product structure diagram
    ACBCUV04517635-21-1In Stock
Inquiry

3. ACBCUV045 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCUV045 route product structure diagram
    ACBCUV04517635-21-1In Stock
Inquiry

Comments (0)